+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Glycated Hemoglobin Testing Market by Test Type, Product Type, Technology, Indication, End User - Global Forecast 2026-2032- Product Image
Glycated Hemoglobin Testing Market by Test Type, Product Type, Technology, Indication, End User - Global Forecast 2026-2032- Product Image
Sale

Glycated Hemoglobin Testing Market by Test Type, Product Type, Technology, Indication, End User - Global Forecast 2026-2032

  • Report

  • 198 Pages
  • June 2026
  • Region: Global
  • 360iResearch™
  • ID: 4904570
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Glycated Hemoglobin Testing Market is projected to reach USD 2.33 Billion in 2026. It is expected to continue growing at a CAGR of 7.76%, reaching USD 3.66 Billion by 2032.

Glycated hemoglobin testing, widely known as HbA1c testing, is a cornerstone of diabetes diagnosis and long-term glycemic monitoring because it reflects average blood glucose exposure over roughly the prior two to three months. The World Health Organization and the American Diabetes Association recognize HbA1c of 6.5% or higher, when measured with standardized methods, as a diagnostic threshold for diabetes.

Demand is being reinforced by the global diabetes burden, with WHO reporting that more than 800 million people were living with diabetes in 2022. Adoption is also supported by broader screening, laboratory automation, point-of-care HbA1c testing, and quality standardization through NGSP and IFCC-aligned methods that improve comparability across laboratories and care settings.

Transformative Shifts in the HbA1c Testing Landscape

The HbA1c testing landscape is shifting from periodic central-laboratory testing toward connected, decentralized, and patient-centered models. Primary care clinics, pharmacies, and community health programs are increasingly using rapid HbA1c platforms to support earlier therapy adjustment, improve diabetes screening workflows, and reduce follow-up delays.

At the same time, clinical use is becoming more nuanced. Continuous glucose monitoring provides real-time glucose variability data, but HbA1c remains essential for diabetes diagnosis, risk stratification, payer reporting, and longitudinal outcomes assessment. Instrument developers and laboratory networks are responding with smaller analyzers, improved sample handling, automated calibration, and stronger quality-control systems.

Cumulative Impact of Artificial Intelligence on HbA1c Testing

Artificial intelligence is creating cumulative value across the HbA1c testing workflow rather than replacing the assay itself. AI-enabled laboratory information systems can flag abnormal result patterns, identify patients overdue for testing, support reflex testing protocols, and improve population-level diabetes management by linking HbA1c values with longitudinal clinical records.

In instrument operations, predictive maintenance and automated quality-control analytics can reduce downtime and help laboratories maintain compliance with accreditation expectations. In clinical care, AI models that combine HbA1c with medications, comorbidities, kidney function, cardiovascular risk, and social determinants can improve risk stratification while requiring strong governance, transparent validation, and bias monitoring.

Key Regional Insights Across Global HbA1c Testing

Asia-Pacific is a major demand center for glycated hemoglobin testing due to large diabetes populations in China, India, Japan, Australia, and South Korea, alongside expanding diagnostic infrastructure, urban primary care networks, and rising use of automated laboratory systems. North America remains highly mature, supported by routine diabetes screening, established reimbursement pathways, CLIA-waived point-of-care HbA1c testing in the United States, and strong adoption of high-throughput analyzers across hospital and reference laboratories.

Latin America is advancing through public health screening initiatives and private laboratory networks, especially in Brazil and Mexico, where access and affordability remain central to adoption. Europe benefits from standardized laboratory quality frameworks, national diabetes programs, and widespread use of accredited diagnostic pathways. The Middle East is investing in chronic disease management amid high metabolic disease prevalence, particularly across Gulf health systems, while Africa shows long-term potential as diabetes awareness increases but requires affordable testing, stronger supply chains, workforce expansion, and improved access outside major urban centers.

Key Group Insights for HbA1c Testing Adoption

ASEAN demand is supported by urbanization, rising obesity, and stronger primary care investment, with point-of-care HbA1c platforms improving access beyond tertiary hospitals and supporting earlier diabetes intervention. GCC markets are shaped by high diabetes prevalence, preventive health strategies, national screening programs, and premium diagnostic infrastructure across Gulf health systems.

The European Union benefits from harmonized quality expectations, accredited laboratory systems, and broad public reimbursement, while BRICS countries combine large patient pools with expanding domestic diagnostics capacity and growing chronic disease programs. G7 markets lead in automation, informatics, quality assurance, and guideline-driven diabetes testing. NATO countries broadly reflect strong hospital networks, regulated procurement standards, and established laboratory capacity, although HbA1c adoption varies by national reimbursement policies, laboratory consolidation, and primary care access.

Key Country Insights Shaping HbA1c Testing Demand

The United States leads through guideline-based diabetes care, high routine testing use, established reimbursement, and a strong point-of-care ecosystem, while Canada emphasizes quality-assured laboratory testing within publicly funded care. Mexico and Brazil are expanding access through primary care screening, public health programs, and private diagnostics, though affordability, geographic access, and reagent availability remain important for consistent HbA1c testing.

In Europe, the United Kingdom, Germany, France, Italy, and Spain benefit from structured diabetes care pathways, accredited laboratories, and established chronic disease monitoring, while Russia relies on broad regional laboratory networks to support testing access across diverse geographies. China and India represent substantial testing demand driven by large diabetes populations, urbanization, and expanding healthcare infrastructure. Japan and South Korea emphasize precision, automation, laboratory quality, and aging-population management, while Australia supports standardized chronic disease monitoring through established primary care pathways and national diabetes care practices.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize assay accuracy, NGSP/IFCC traceability, lot-to-lot consistency, and robust quality-control documentation, particularly as HbA1c testing expands beyond central laboratories into primary care and community settings. Product portfolios should address both high-throughput laboratories and decentralized sites with clear operator training, intuitive workflows, connectivity, regulatory support, and service reliability.

Organizations should also invest in interoperability with electronic health records, AI-enabled patient recall tools, and education around HbA1c limitations in anemia, hemoglobin variants, chronic kidney disease, pregnancy, altered red blood cell turnover, and recent transfusion. Regional pricing, reagent availability, local technical support, and resilient distribution networks will be critical differentiators in emerging markets and underserved care settings.

Research Methodology

This executive summary is built from a structured review of clinical guidelines, public health datasets, regulatory references, laboratory standardization frameworks, peer-reviewed evidence, and health-system indicators. Key sources include WHO diabetes data, ADA Standards of Care, NGSP and IFCC standardization principles, and regional diagnostic policy references.

The methodology evaluates demand conditions through disease prevalence, screening policy, reimbursement structures, installed diagnostic capacity, point-of-care adoption, laboratory accreditation, digital health readiness, and technology integration. Insights are triangulated across regional, economic group, and country-level evidence to support practical strategic interpretation without relying on market estimation, market sizing, market share, or forecasting.

Conclusion

Glycated hemoglobin testing remains indispensable to diabetes care because it provides standardized, clinically actionable evidence of long-term glycemic control. Even as continuous glucose monitoring expands, HbA1c continues to anchor diabetes diagnosis, therapy assessment, quality metrics, risk stratification, and population health programs.

Future advancement will depend on reliable decentralization, AI-supported workflows, affordability, quality standardization, and improved access in underserved settings. Organizations that combine analytical quality with digital integration, operator simplicity, and region-specific commercialization strategies will be best positioned to strengthen HbA1c testing access and clinical value.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Glycated Hemoglobin Testing Market, by Test Type
7.1. Laboratory-Based Testing
7.2. Point-of-Care (POC) Testing
8. Glycated Hemoglobin Testing Market, by Product Type
8.1. Instruments
8.1.1. Bench-Top Analyzers
8.1.2. Portable Analyzers
8.2. Reagents & Consumables
9. Glycated Hemoglobin Testing Market, by Technology
9.1. Boronate Affinity Chromatography
9.2. Electrophoresis
9.3. Enzymatic Assays
9.4. High-Performance Liquid Chromatography (HPLC)
9.5. Immunoassay Methods
10. Glycated Hemoglobin Testing Market, by Indication
10.1. Diabetes Diagnosis
10.2. Routine Monitoring
11. Glycated Hemoglobin Testing Market, by End User
11.1. Diagnostic Laboratories
11.2. Home Care
11.3. Hospital & Clinics
11.4. Research Institutions
12. Asia-Pacific Glycated Hemoglobin Testing Market
13. Europe Glycated Hemoglobin Testing Market
14. North America Glycated Hemoglobin Testing Market
15. Latin America Glycated Hemoglobin Testing Market
16. Middle East Glycated Hemoglobin Testing Market
17. Africa Glycated Hemoglobin Testing Market
18. NATO Glycated Hemoglobin Testing Market
19. G7 Glycated Hemoglobin Testing Market
20. European Union Glycated Hemoglobin Testing Market
21. BRICS Glycated Hemoglobin Testing Market
22. ASEAN Glycated Hemoglobin Testing Market
23. GCC Glycated Hemoglobin Testing Market
24. China Glycated Hemoglobin Testing Market
25. United States Glycated Hemoglobin Testing Market
26. Germany Glycated Hemoglobin Testing Market
27. India Glycated Hemoglobin Testing Market
28. Japan Glycated Hemoglobin Testing Market
29. United Kingdom Glycated Hemoglobin Testing Market
30. France Glycated Hemoglobin Testing Market
31. South Korea Glycated Hemoglobin Testing Market
32. Italy Glycated Hemoglobin Testing Market
33. Canada Glycated Hemoglobin Testing Market
34. Brazil Glycated Hemoglobin Testing Market
35. Australia Glycated Hemoglobin Testing Market
36. Spain Glycated Hemoglobin Testing Market
37. Mexico Glycated Hemoglobin Testing Market
38. Russia Glycated Hemoglobin Testing Market
39. Competitive Landscape
39.1. Market Concentration Analysis, 2025
39.1.1. Concentration Ratio (CR)
39.1.2. Herfindahl Hirschman Index (HHI)
39.2. Recent Developments & Impact Analysis, 2025
39.3. Product Portfolio Analysis, 2025
39.4. Benchmarking Analysis, 2025
40. Company Profiles
40.1. Abbott Laboratories Inc.
40.2. F. Hoffmann-La Roche AG
40.3. Danaher Corporation
40.4. Siemens Healthineers AG
40.5. Bio-Rad Laboratories, Inc.
40.6. ARKRAY, Inc.
40.7. Tosoh Corporation
40.8. Sysmex Corporation
40.9. EKF Diagnostics Holdings plc
40.10. Nova Biomedical Corporation
40.11. Randox Laboratories Ltd.
40.12. DiaSys Diagnostic Systems GmbH
40.13. Sinocare Inc.
40.14. Sebia S.A.
40.15. HUMAN Gesellschaft für Biochemica und Diagnostica mbH
40.16. TaiDoc Technology Corporation
40.17. Diazyme Laboratories, Inc.
40.18. Daiichi Biotech Services Sdn. Bhd.
40.19. Lifotronic Technology Co., Ltd.
40.20. Metropolis Healthcare Limited
40.21. Quest Diagnostics
40.22. SAKAE Co., Ltd.
40.23. Trinity Biotech Plc.
List of Figures
FIGURE 1. GLOBAL GLYCATED HEMOGLOBIN TESTING MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL GLYCATED HEMOGLOBIN TESTING MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL GLYCATED HEMOGLOBIN TESTING MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL GLYCATED HEMOGLOBIN TESTING MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL GLYCATED HEMOGLOBIN TESTING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 6. GLOBAL GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 7. GLOBAL GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 9. GLOBAL GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 11. GLOBAL GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL GLYCATED HEMOGLOBIN TESTING MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 13. GLOBAL GLYCATED HEMOGLOBIN TESTING MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
FIGURE 14. GLOBAL GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TEST TYPE, 2025 VS 2032 (%)
FIGURE 15. GLOBAL GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TEST TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
FIGURE 17. GLOBAL GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
FIGURE 19. GLOBAL GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY INDICATION, 2025 VS 2032 (%)
FIGURE 21. GLOBAL GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY INDICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 23. GLOBAL GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 24. ASIA-PACIFIC GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 25. ASIA-PACIFIC GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 26. EUROPE GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 27. EUROPE GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 28. NORTH AMERICA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 29. NORTH AMERICA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 30. LATIN AMERICA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 31. LATIN AMERICA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 32. MIDDLE EAST GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 33. MIDDLE EAST GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 34. AFRICA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 35. AFRICA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 36. NATO GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 37. NATO GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 38. G7 GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 39. G7 GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 40. EUROPEAN UNION GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 41. EUROPEAN UNION GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 42. BRICS GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 43. BRICS GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 44. ASEAN GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 45. ASEAN GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 46. GCC GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 47. GCC GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 48. CHINA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 49. UNITED STATES GLYCATED HEMOGLOBIN TESTING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 50. GERMANY GLYCATED HEMOGLOBIN TESTING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 51. INDIA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 52. JAPAN GLYCATED HEMOGLOBIN TESTING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 53. UNITED KINGDOM GLYCATED HEMOGLOBIN TESTING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 54. FRANCE GLYCATED HEMOGLOBIN TESTING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 55. SOUTH KOREA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 56. ITALY GLYCATED HEMOGLOBIN TESTING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 57. CANADA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 58. BRAZIL GLYCATED HEMOGLOBIN TESTING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 59. AUSTRALIA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 60. SPAIN GLYCATED HEMOGLOBIN TESTING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 61. MEXICO GLYCATED HEMOGLOBIN TESTING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 62. RUSSIA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL GLYCATED HEMOGLOBIN TESTING MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL GLYCATED HEMOGLOBIN TESTING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL GLYCATED HEMOGLOBIN TESTING MARKET SHARE, BY KEY PLAYER, 2025
TABLE 7. GLOBAL GLYCATED HEMOGLOBIN TESTING MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
TABLE 8. GLOBAL GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL LABORATORY-BASED TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL LABORATORY-BASED TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL LABORATORY-BASED TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL POINT-OF-CARE (POC) TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL POINT-OF-CARE (POC) TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL POINT-OF-CARE (POC) TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL INSTRUMENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL INSTRUMENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL INSTRUMENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL BENCH-TOP ANALYZERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL BENCH-TOP ANALYZERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL BENCH-TOP ANALYZERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL PORTABLE ANALYZERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL PORTABLE ANALYZERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL PORTABLE ANALYZERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL REAGENTS & CONSUMABLES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL REAGENTS & CONSUMABLES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL REAGENTS & CONSUMABLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL BORONATE AFFINITY CHROMATOGRAPHY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL BORONATE AFFINITY CHROMATOGRAPHY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL BORONATE AFFINITY CHROMATOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL ELECTROPHORESIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL ELECTROPHORESIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL ELECTROPHORESIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL ENZYMATIC ASSAYS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL ENZYMATIC ASSAYS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL ENZYMATIC ASSAYS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY (HPLC) MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY (HPLC) MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY (HPLC) MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL IMMUNOASSAY METHODS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL IMMUNOASSAY METHODS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL IMMUNOASSAY METHODS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL DIABETES DIAGNOSIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL DIABETES DIAGNOSIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL DIABETES DIAGNOSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL ROUTINE MONITORING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL ROUTINE MONITORING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL ROUTINE MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL DIAGNOSTIC LABORATORIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL DIAGNOSTIC LABORATORIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL DIAGNOSTIC LABORATORIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL HOME CARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL HOME CARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL HOME CARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL HOSPITAL & CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL HOSPITAL & CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL HOSPITAL & CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL RESEARCH INSTITUTIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL RESEARCH INSTITUTIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL RESEARCH INSTITUTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 64. ASIA-PACIFIC GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 65. ASIA-PACIFIC GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 66. ASIA-PACIFIC GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 67. ASIA-PACIFIC GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 68. ASIA-PACIFIC GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 69. ASIA-PACIFIC GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 70. ASIA-PACIFIC GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 71. EUROPE GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 72. EUROPE GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 73. EUROPE GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 74. EUROPE GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 75. EUROPE GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 76. EUROPE GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 77. EUROPE GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 78. NORTH AMERICA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 79. NORTH AMERICA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 80. NORTH AMERICA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 81. NORTH AMERICA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 82. NORTH AMERICA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 83. NORTH AMERICA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 84. NORTH AMERICA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 85. LATIN AMERICA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 86. LATIN AMERICA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 87. LATIN AMERICA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 88. LATIN AMERICA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 89. LATIN AMERICA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 90. LATIN AMERICA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 91. LATIN AMERICA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 92. MIDDLE EAST GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 93. MIDDLE EAST GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 94. MIDDLE EAST GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 95. MIDDLE EAST GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 96. MIDDLE EAST GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 97. MIDDLE EAST GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 98. MIDDLE EAST GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 99. AFRICA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 100. AFRICA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 101. AFRICA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 102. AFRICA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 103. AFRICA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 104. AFRICA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 105. AFRICA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 106. NATO GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 107. NATO GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 108. NATO GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 109. NATO GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 110. NATO GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 111. NATO GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 112. NATO GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 113. G7 GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 114. G7 GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 115. G7 GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 116. G7 GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 117. G7 GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 118. G7 GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 119. G7 GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 120. EUROPEAN UNION GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 121. EUROPEAN UNION GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 122. EUROPEAN UNION GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 123. EUROPEAN UNION GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 124. EUROPEAN UNION GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 125. EUROPEAN UNION GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 126. EUROPEAN UNION GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 127. BRICS GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 128. BRICS GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 129. BRICS GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 130. BRICS GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 131. BRICS GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 132. BRICS GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 133. BRICS GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 134. ASEAN GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 135. ASEAN GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 136. ASEAN GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 137. ASEAN GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 138. ASEAN GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 139. ASEAN GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 140. ASEAN GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 141. GCC GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 142. GCC GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 143. GCC GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 144. GCC GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 145. GCC GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 146. GCC GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 147. GCC GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 148. CHINA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 149. CHINA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 150. CHINA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 151. CHINA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 152. CHINA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 153. CHINA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 154. CHINA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 155. UNITED STATES GLYCATED HEMOGLOBIN TESTING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 156. UNITED STATES GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 157. UNITED STATES GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 158. UNITED STATES GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 159. UNITED STATES GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 160. UNITED STATES GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 161. UNITED STATES GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 162. GERMANY GLYCATED HEMOGLOBIN TESTING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 163. GERMANY GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 164. GERMANY GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 165. GERMANY GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 166. GERMANY GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 167. GERMANY GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 168. GERMANY GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 169. INDIA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 170. INDIA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 171. INDIA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 172. INDIA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 173. INDIA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 174. INDIA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 175. INDIA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 176. JAPAN GLYCATED HEMOGLOBIN TESTING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 177. JAPAN GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 178. JAPAN GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 179. JAPAN GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 180. JAPAN GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 181. JAPAN GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 182. JAPAN GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 183. UNITED KINGDOM GLYCATED HEMOGLOBIN TESTING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 184. UNITED KINGDOM GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 185. UNITED KINGDOM GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 186. UNITED KINGDOM GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 187. UNITED KINGDOM GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 188. UNITED KINGDOM GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 189. UNITED KINGDOM GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 190. FRANCE GLYCATED HEMOGLOBIN TESTING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 191. FRANCE GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 192. FRANCE GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 193. FRANCE GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 194. FRANCE GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 195. FRANCE GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 196. FRANCE GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 197. SOUTH KOREA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 198. SOUTH KOREA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 199. SOUTH KOREA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 200. SOUTH KOREA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 201. SOUTH KOREA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 202. SOUTH KOREA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 203. SOUTH KOREA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 204. ITALY GLYCATED HEMOGLOBIN TESTING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 205. ITALY GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 206. ITALY GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 207. ITALY GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 208. ITALY GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 209. ITALY GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 210. ITALY GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 211. CANADA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 212. CANADA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 213. CANADA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 214. CANADA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 215. CANADA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 216. CANADA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 217. CANADA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 218. BRAZIL GLYCATED HEMOGLOBIN TESTING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 219. BRAZIL GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 220. BRAZIL GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 221. BRAZIL GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 222. BRAZIL GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 223. BRAZIL GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 224. BRAZIL GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 225. AUSTRALIA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 226. AUSTRALIA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 227. AUSTRALIA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 228. AUSTRALIA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 229. AUSTRALIA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 230. AUSTRALIA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 231. AUSTRALIA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 232. SPAIN GLYCATED HEMOGLOBIN TESTING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 233. SPAIN GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 234. SPAIN GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 235. SPAIN GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 236. SPAIN GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 237. SPAIN GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 238. SPAIN GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 239. MEXICO GLYCATED HEMOGLOBIN TESTING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 240. MEXICO GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 241. MEXICO GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 242. MEXICO GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 243. MEXICO GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 244. MEXICO GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 245. MEXICO GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 246. RUSSIA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 247. RUSSIA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 248. RUSSIA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 249. RUSSIA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 250. RUSSIA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 251. RUSSIA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 252. RUSSIA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)

Companies Mentioned

The companies featured in this Glycated Hemoglobin Testing market report include:
  • Abbott Laboratories Inc.
  • F. Hoffmann-La Roche AG
  • Danaher Corporation
  • Siemens Healthineers AG
  • Bio-Rad Laboratories, Inc.
  • ARKRAY, Inc.
  • Tosoh Corporation
  • Sysmex Corporation
  • EKF Diagnostics Holdings plc
  • Nova Biomedical Corporation
  • Randox Laboratories Ltd.
  • DiaSys Diagnostic Systems GmbH
  • Sinocare Inc.
  • Sebia S.A.
  • HUMAN Gesellschaft für Biochemica und Diagnostica mbH
  • TaiDoc Technology Corporation
  • Diazyme Laboratories, Inc.
  • Daiichi Biotech Services Sdn. Bhd.
  • Lifotronic Technology Co., Ltd.
  • Metropolis Healthcare Limited
  • Quest Diagnostics
  • SAKAE Co., Ltd.
  • Trinity Biotech Plc.

Table Information

Report AttributeDetails
No. of Pages198
PublishedJune 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 2.33 Billion
Forecasted Market Value ( USD ) by 2032 $ 3.66 Billion
Compound Annual Growth Rate7.7%
Regions CoveredGlobal
No. of Companies Mentioned24

Related Topics

Related Reports

Hemoglobin A1C (HbA1C) Testing - Global Strategic Business Report - Product Image

Hemoglobin A1C (HbA1C) Testing - Global Strategic Business Report

  • Report
  • 511 Pages
  • Global
From
Hemoglobin A1c Testing Devices Market Report 2026 - Product Image

Hemoglobin A1c Testing Devices Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Hemoglobin Testing Market - Global Forecast 2026-2032 - Product Image

Hemoglobin Testing Market - Global Forecast 2026-2032

  • Report
  • 195 Pages
  • Global
From
Hemoglobin A1c Analyzer Market by Product Type, Technology, Testing Type, Sample Type, Automation Level, Throughput Capacity, Distribution Channel, Application, End User - Global Forecast 2026-2032 - Product Image

Hemoglobin A1c Analyzer Market by Product Type, Technology, Testing Type, Sample Type, Automation Level, Throughput Capacity, Distribution Channel, Application, End User - Global Forecast 2026-2032

  • Report
  • 195 Pages
  • Global
From
Hemoglobin A1c (HbA1c) Testing Market Report 2026 - Product Image

Hemoglobin A1c (HbA1c) Testing Market Report 2026

  • Report
  • 250 Pages
  • Global
From

About the HbA1C Testing Market

The HbA1C Testing market within the Biotechnology industry is a rapidly growing sector. It is used to measure the average amount of glucose in the blood over a period of two to three months. This test is used to diagnose and monitor diabetes, as well as to assess the effectiveness of diabetes treatments. It is also used to detect pre-diabetes and to monitor the risk of developing diabetes. The HbA1C Testing market is driven by the increasing prevalence of diabetes, the growing awareness of the importance of early diagnosis and treatment, and the availability of advanced testing technologies. The market is also supported by the increasing demand for point-of-care testing and the development of new products. Some of the major companies in the HbA1C Testing market include Abbott Laboratories, Roche Diagnostics, Siemens Healthineers, Alere, and Bio-Rad Laboratories. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.